Treating hyperkalemia in patients with HF10' education - Sep. 26, 2023 - Mikhail Kosiborod, MD - Kansas City, MO, USA
Video navigation menu
- Clinical case 00:16
- Treatment options for hyperkalemia 05:01
- Novel potassium binders: patiromer and SZC 07:38
- Summary 11:58
This lecture by Mikhail Kosiborod, MD was part of the EBAC-accredited symposium "Tackling the risk of hyperkalemia through guideline-recommended heart failure therapy" held at the ESC Congress 2023, Amsterdam, The Netherlands.
Mikhail Kosiborod, MD is a Cardiologist and Vice President of Research at Saint Luke’s Health System, Executive Director of the Cardiometabolic Center Alliance, Director of Cardiometabolic Research and Co-Director of the Haverty Cardiometabolic Center of Excellence at Saint Luke’s Mid America Heart Institute, and Professor of Medicine at the University of Missouri-Kansas City.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from AstraZeneca.